Page 20 - Read Online

Li et al. Ageing Neur Dis 2022;2:12 https://dx.doi.org/10.20517/and.2022.14 Page 11 of 13

2009;461:916-22. DOI PubMed PMC
55. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. The
Lancet Neurology 2014;13:614-29. DOI PubMed
56. Kunkle BW, Grenier-Boley B, Sims R, et al; Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease
Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE); Genetic and
Environmental Risk in AD/Defining Genetic; Polygenic and Environmental Risk for Alzheimer’s Disease Consortium
(GERAD/PERADES). Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau,
immunity and lipid processing. Nat Genet 2019;51:414-30. DOI PubMed PMC
57. Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer’s disease. Nat Rev Dis Primers
2015;1:15056. DOI PubMed
58. Götz J, Ittner LM. Animal models of Alzheimer’s disease and frontotemporal dementia. Nat Rev Neurosci 2008;9:532-44. DOI
PubMed
59. Sakakibara Y, Sekiya M, Saito T, Saido TC, Iijima KM. Amyloid-β plaque formation and reactive gliosis are required for induction
of cognitive deficits in App knock-in mouse models of Alzheimer’s disease. BMC Neurosci 2019;20:13. DOI PubMed PMC
60. McGowan E, Eriksen J, Hutton M. A decade of modeling Alzheimer’s disease in transgenic mice. Trends Genet 2006;22:281-9. DOI
PubMed
61. Sasaguri H, Hashimoto S, Watamura N, et al. Recent advances in the modeling of Alzheimer’s disease. Front Neurosci
2022;16:807473. DOI PubMed PMC
62. Flood DG, Lin YG, Lang DM, et al. A transgenic rat model of Alzheimer’s disease with extracellular Abeta deposition. Neurobiol
Aging 2009;30:1078-90. DOI PubMed
63. Elder GA, Gama Sosa MA, De Gasperi R, Dickstein DL, Hof PR. Presenilin transgenic mice as models of Alzheimer’s disease. Brain
Struct Funct 2010;214:127-43. DOI PubMed PMC
64. Leuzy A, Smith R, Ossenkoppele R, et al. Diagnostic performance of RO948 F 18 tau positron emission tomography in the
differentiation of Alzheimer disease from other neurodegenerative disorders. JAMA Neurol 2020;77:955-65. DOI PubMed PMC
65. Götz J, Gladbach A, Pennanen L, et al. Animal models reveal role for tau phosphorylation in human disease. Biochim Biophys Acta
2010;1802:860-71. DOI PubMed
66. Eskandari-Sedighi G, Daude N, Gapeshina H, et al. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent
tau seeding capacity yet focal and diverse patterns of protein deposition. Mol Neurodegener 2017;12:72. DOI PubMed PMC
67. Myers A, McGonigle P. Overview of transgenic mouse models for Alzheimer’s disease. Curr Protoc Neurosci 2019;89:e81. DOI
PubMed
68. Esquerda-Canals G, Montoliu-Gaya L, Guell-Bosch J, Villegas S. Mouse models of Alzheimer’s disease. J Alzheimers Dis
2017;57:1171-83. DOI PubMed
69. Kragh PM, Nielsen AL, Li J, et al. Hemizygous minipigs produced by random gene insertion and handmade cloning express the
Alzheimer’s disease-causing dominant mutation APPsw. Transgenic Res 2009;18:545-58. DOI PubMed
70. Jakobsen JE, Johansen MG, Schmidt M, et al. Generation of minipigs with targeted transgene insertion by recombinase-mediated
cassette exchange (RMCE) and somatic cell nuclear transfer (SCNT). Transgenic Res 2013;22:709-23. DOI PubMed PMC
71. Søndergaard LV, Ladewig J, Dagnæs-Hansen F, Herskin MS, Holm IE. Object recognition as a measure of memory in 1-2 years old
transgenic minipigs carrying the APPsw mutation for Alzheimer’s disease. Transgenic Res 2012;21:1341-8. DOI PubMed
72. King A. The search for better animal models of Alzheimer’s disease. Nature 2018;559:S13-5. DOI PubMed
73. Beckman D, Morrison JH. Towards developing a rhesus monkey model of early Alzheimer’s disease focusing on women’s health.
Am J Primatol 2021;83:e23289. DOI PubMed
74. Heuer E, Rosen RF, Cintron A, Walker LC. Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des
2012;18:1159-69. DOI PubMed PMC
75. Paspalas CD, Carlyle BC, Leslie S, et al. The aged rhesus macaque manifests Braak stage III/IV Alzheimer’s-like pathology.
Alzheimers Dement 2018;14:680-91. DOI PubMed PMC
76. Arnsten AFT, Datta D, Leslie S, Yang ST, Wang M, Nairn AC. Alzheimer’s-like pathology in aging rhesus macaques: unique
opportunity to study the etiology and treatment of Alzheimer’s disease. Proc Natl Acad Sci U S A ;2019:26230-8. DOI PubMed
PMC
77. Arnsten AFT, Datta D, Preuss TM. Studies of aging nonhuman primates illuminate the etiology of early-stage Alzheimer’s-like
neuropathology: An evolutionary perspective. Am J Primatol 2021;83:e23254. DOI PubMed PMC
78. Yang M, Miao J, Rizak J, et al. Alzheimer’s disease and methanol toxicity (part 2): lessons from four rhesus macaques (Macaca
mulatta) chronically fed methanol. J Alzheimers Dis 2014;41(4):1131-47. DOI PubMed
79. Zhai R, Rizak J, Zheng N, et al. Alzheimer’s disease-like pathologies and cognitive impairments induced by formaldehyde in non-
human primates. Curr Alzheimer Res 2018;15:1304-21. DOI PubMed
80. Beckman D, Ott S, Donis-Cox K, et al. Oligomeric Aβ in the monkey brain impacts synaptic integrity and induces accelerated
cortical aging. Proc Natl Acad Sci U S A ;2019:26239-46. DOI PubMed PMC
81. Forny-Germano L, Lyra e Silva NM, Batista AF, et al. Alzheimer’s disease-like pathology induced by amyloid-β oligomers in
nonhuman primates. J Neurosci 2014;34:13629-43. DOI PubMed PMC
82. Yue F, Feng S, Lu C, et al. Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer’s disease in nonhuman